Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer

NCT00002760 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

260

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: ketoconazole
DRUG: therapeutic hydrocortisone
OTHER: Withdrawal of antiandrogen therapy

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]